Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
- Type
- Retraction
- Notice date
- 9/18/2021 0:00
- Journal
- Scientific Reports
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41598-021-98683-5
- Original paper DOI
- 10.1038/s41598-021-85227-0
Reasons
- Concerns/Issues about Data
- Results Not Reproducible
- Unreliable Data
- Unreliable Results and/or Conclusions